Cite

HARVARD Citation

    He, L. et al. (n.d.). Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record